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Objective: “Chimney” techniques used to extend landing zones for endovascular aortic repair (chEVAR) have been
increasingly reported; however, concerns about durability and patency remain. The purpose of this analysis was to
examine midterm outcomes of chEVAR.
Methods: All patients at the University of Florida treated with chEVAR were reviewed. Major adverse events (MAEs) were
recorded and deﬁned as any chimney stent thrombosis, type Ia endoleak in follow-up, reintervention, 30-day/in-hospital
death, or $25% decrease in estimated glomerular ﬁltration rate after discharge. Primary end points included chimney
stent patency and freedom from MAE. Secondary end points included complications and long-term survival.
Results: From 2008 to 2012, 41 patients (age 6 standard deviation, 73 6 8 years; male, 66% [n[ 27]) were treated with
a total of 76 chimney stents (renal, n [ 51; superior mesenteric artery, n [ 16; celiac artery, n [ 9) for a variety of
indications: juxtarenal, 42% (n [ 17, one rupture), suprarenal, 17% (n [ 7), and thoracoabdominal aneurysm, 17%
(n[ 7); aortic anastomotic pseudoaneurysm, 15% (n[ 6; three ruptures); type Ia endoleak after EVAR, 7% (n[ 3); and
atheromatous disease, 2% (n [ 1). Two patients had a single target vessel abandoned because of cannulation failure,
and one had a type Ia endoleak at case completion (technical success, 93%). Intraoperative complications occurred in seven
patients (17%), including graft maldeployment with unplanned mesenteric chimney (n [ 2) and access vessel injury
requiring repair (n [ 5). Major postoperative complications developed in 20% (n [ 8). The 30-day mortality and in-
hospital mortality were 5% (n [ 2) and 7% (n [ 3), respectively. At median follow-up of 18.2 months (range,
1.4-41.5 months), 28 of 33 patients (85%) with available postoperative imaging experienced stabilization or reduction of
abdominal aortic aneurysm sac diameters. Nine patients (32%) developed endoleak at some point during follow-up (type
Ia, 7% [n[ 3]; type II, 10% [n[ 4]; indeterminate, 7% [n[ 3]), and one patient underwent open, surgical conversion.
The estimated probability of freedom from reintervention (6standard error mean) was 96% 6 4% at both 1 year and
3 years. Primary patency of all chimney stents was 88% 6 5% and 85% 6 5% at 1 year and 3 years, respectively. Corre-
sponding freedom fromMAEs was 83%6 7% and 57%6 10% at 1 year and 3 years. The actuarial estimated survival for all
patients at 1 year and 5 years was 85% 6 6% and 65% 6 8%, respectively.
Conclusions: These results demonstrate that chEVAR can be completed with a high degree of success; however, periop-
erative complications and MAEs during follow-up, including loss of chimney patency and endoleak, may occur at a higher
rate than previously reported. Elective use of chEVAR should be performed with caution, and comparison to open and
fenestrated EVAR is needed to determine long-term efﬁcacy of this technique. (J Vasc Surg 2014;60:865-75.)the Division of Vascular Surgery and Endovascular Therapy, Univer-
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://dx.doi.org/10.1016/j.jvs.2014.03.295Approximately 20% to 30% of patients are unsuitable
anatomic candidates for standard endovascular aortic aneu-
rysm repair (EVAR).1,2Within this subgroup, 50% to 60% of
cases are ineligible for EVAR because of proximal aortic
neck anatomy limitations.2,3 To overcome these challenges,
a variety of endovascular procedures have emerged to
extend proximal landing zones, including custom fenes-
trated/branched grafts and surgeon-modiﬁed devices as
well as chimney, periscope, and sandwich EVAR techniques.
The chimney technique (chEVAR) was originally described
as an adjunctive salvage procedure to treat unintentionally
covered branch vessels.4 However, multiple reports of
short-term success have led to increasing enthusiasm for
chEVAR, and these techniques are being used for primary
treatment of juxtarenal as well as of suprarenal and thora-
coabdominal aortic diseases.5-8
Despite early success of the chEVAR procedure, many
concerns about durability remain. The worldwide reported
chEVAR experience is composed of <300 patients
with <400 target vessels with a mean follow-up
of <11 months.7-10 The limited published experience with865
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tient or anatomic selection criteria as well as for device
choice, implantation technique, and surveillance. Further-
more, the lack of prospective data comparing chEVAR to
open aortic or fenestrated/branched repair makes it difﬁcult
to deﬁne what role chEVAR should have in contemporary
practice. Last, few data exist regarding major adverse events
(MAEs) during follow-up (eg, change in renal function,
stent thrombosis, reintervention, mortality) after chEVAR
and their clinical consequences.
The purpose of this analysis was to review our experi-
ence with chEVAR and to report our midterm outcomes.
METHODS
Approval for this study was obtained from the Univer-
sity of Florida College of Medicine Institutional Review
Board (#161-2012). A waiver of informed consent was
granted because all collected data pre-existed in medical re-
cords and no study related interventions or subject contact
occurred. Therefore, the rights and welfare of these sub-
jects was not adversely affected.
Database, deﬁnitions, and subjects. A retrospective
review of a prospectively maintained endovascular aortic
registry was completed to analyze all chEVAR procedures
performed at the University of Florida from January
2008 to December 2012. The chimney technique was
deﬁned as intentional deployment of a stent/stent graft
into visceral aortic branch vessels immediately parallel to
an aortic endoprosthesis that covered the target vessel
ostia. Sandwich5 and periscope11 techniques were selec-
tively used and reviewed in this analysis. Brachiocephalic or
internal iliac artery chimney stents were excluded unless
patients received a visceral aortic branch chimney stent. In
these cases, the brachiocephalic or internal iliac artery stent
was recorded as a procedural adjunct and not analyzed as a
chimney stent. Similarly, patients undergoing fenestrated/
branched repair were included only if they simultaneously
received a visceral aortic chimney stent.
Comorbidities were deﬁned and severity was graded by
Society for Vascular Surgery (SVS) reporting guidelines
(high-risk$8)12 (SupplementaryTable I, onlineonly). Stent
patency, procedure-related success, adjuncts, endoleaks, and
complication severity were deﬁned by SVS reporting stan-
dards.13 Stent patency was veriﬁed by contrast opaciﬁcation
on follow-up computed tomography angiography (CTA) or
with duplex ultrasound. Centerline measurements
(Aquarius 3D; TeraRecon Inc, San Mateo, Calif) were
completed on all available preoperative and postoperative
computed tomography (CT) scans to discern aneurysm
and stentmorphology. Aneurysm sac diameterswere consid-
ered stable if <5 mm of growth was measured on postoper-
ative CT scans. Chimney stent compression (ie, kinking) was
documented if imaging demonstrated $50% reduction in
luminal cross-sectional area. Additional anatomic parameters
that weremeasured includedmaximum aortic diameters and
angulation. The chimney neck was measured similar to the
method of Lee et al14 to document the seal zone between
the chimney stent and the aortic endoprosthesis.Clinical practice. All patients received preoperative
thin-cut (#2 mm) CTA (aortic arch to pelvis), and device
planning was completed with a three-dimensional work-
station (Aquarius 3D). Patient and device selection and
implantation technique were left to the surgeon’s discretion.
In general, patients were offered chEVAR only if they were
deemed at high risk for open surgery15 and had anatomic
selection criteria as previously reported from our group.7
Postoperative surveillance consisted of CTA at 1 month,
6 months, and annually thereafter. Excluding patients with
documented allergy, dual antiplatelet therapy was started
postoperatively and consisted of clopidogrel (75 mg/day)
and aspirin (81 mg/day) for at least 1 month, followed by
aspirin 81 mg/day indeﬁnitely. Routine documentation of
blood pressure and antihypertensive regimen occurred with
each follow-up clinic visit. Serum creatinine levels were
checked daily for inpatients and obtained concurrently with
each follow-up CT. If patients had renal insufﬁciency (ie,
estimated glomerular ﬁltration rate [eGFR]<50 mL/min/
1.73 m2), routine surveillance consisted of chimney stent
duplex ultrasound and noncontrast CT.
Timing of and need for reintervention were left to the
operative surgeon’s decision. All type Ia and type III endo-
leaks were considered signiﬁcant and warranted therapy
unless there were compelling medical or anatomic factors
limiting remedial options. Typically, persistent type II
endoleak ($6 months after chEVAR) associated with
$5 mm of aneurysm diameter increase prompted reinter-
vention. Although no formal protocol for reintervention
existed, additional ﬁndings that frequently prompted rein-
tervention included chimney stent luminal cross-sectional
area reduction $50% on CT and visceral or renal duplex
peak systolic velocity $300 cm/s with concurrent eGFR
decrease $25% from the value at discharge.
chEVAR technique. A majority of patients were
repaired in a hybrid operating room with use of a ﬁxed im-
aging system under general anesthesia. Percutaneous bilat-
eral femoral and left brachial access was completed as
previously described for procedures requiring a single
chimney stent.16 If more than one vessel required chim-
ney stent placement, bilateral percutaneous brachial access
or an open axillary conduit was employed. In most cases, a
7F or 8F 90-cm sheath was placed over a 0.035-inch Rosen
wire (Cook Medical, Bloomington, Ind) after successful
target vessel catheterization. If multiple vessels were can-
nulated, individual visceral vessel sheath access was ach-
ieved before aortic endograft deployment. A 20-mm
overlap between the aortic and chimney stents was planned
in a majority of cases. Once the aortic endoprosthesis was
deployed (oversized $20% to outer diameter of seal zone),
the chimney stents (iCAST; Atrium Medical, Hudson,
NH; Viabahn; W. L. Gore & Associates, Flagstaff, Ariz;
Zilver; Cook Medical) were deployed. Additional stents
were placed as needed to ensure that the chimney extended
5 to 10 mm above the aortic stent.
As a ﬁnal step, a simultaneous “kissing” balloon tech-
nique, with an aortic balloon and branch vessel balloon,
was used to mold the proximal seal zone. If completion
Table I. Patient characteristics and comorbidities
Feature N ¼ 41, No. (%)
Age, years, mean 6 SD 73 6 8
Male 27 (66)
BMI 26 6 7
Comorbidities No. (%)
Hypertension 36 (88)
Dyslipidemia 31 (78)
Coronary artery disease 26 (63)
Smoking 23 (56)
Chronic obstructive pulmonary disease 21 (51)
Congestive heart failure 13 (32)
Diabetes 7 (17)
Renal insufﬁciencya 8 (20)
CVOD 6 (15)
PVOD 3 (7)
Composite total, mean 6 SD 3.5 6 1.6
SVS comorbidity score, median (IQR) 7 (6-9)
BMI, Body mass index; CVOD, cerebrovascular occlusive disease; IQR,
interquartile range; PVOD, peripheral vascular occlusive disease; SD, stan-
dard deviation; SVS, Society for Vascular Surgery (comorbidity score $8 ¼
high risk).
aRenal insufﬁciency is estimated glomerular ﬁltration <50 mL/min/
1.73 m2.
Table II. Preoperative anatomy, prior aorta-related
procedures, and clinical presentation
Feature N ¼ 41, No. (%)
AAA diameter (cm 6 SD) 6.5 6 1.2
Previous open aneurysm repair 6 (15)
Prior EVAR 4 (10)
Prior TEVAR 4 (10)
Anatomic indication No. (%)
Juxtarenal AAA 17 (42)
Suprarenal AAA 7 (17)
Postsurgical pseudoaneurysm 6 (15)
Type Ia endoleak after EVAR 3 (7)
Thoracic aneurysm 3 (7)
Type IV TAAA 2 (5)
Type II TAAA 1 (5)
Aortic dissection with aneurysm 1 (2)
Atheromatous disease with embolization 1 (2)
Presentation No. (%)
ASA class 4 37 (90)
Urgent/symptomatic 8 (20)
Emergent/rupture 3 (7)
AAA, Abdominal aortic aneurysm; ASA, American Society of Anesthesi-
ologists; EVAR, endovascular abdominal aortic aneurysm repair; SD, stan-
dard deviation; TAAA, Crawford extent thoracoabdominal aneurysm;
TEVAR, thoracic endovascular aortic repair.
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ballooning was performed. In selected cases, a self-
expanding stent was placed within the chimney stent and
extended into the native vessel to ease the transition between
the rigid stent graft and compliant target vessel to prevent
kinking. Finally, selective use of intravascular ultrasound
occurred to verify chimney stent expansion or relative posi-
tion to the top of the aortic endoprosthesis.
End points, deﬁnitions, and statistics. Primary end
points included chimney stent patency and freedom from
MAEs. Secondary end points included complications and
long-term survival. MAEs were deﬁned as a composite
end point that included any chimney stent thrombosis, type
Ia endoleak in follow-up, reintervention, 30-day/in-
hospital death, or $25% decrease in eGFR after discharge.
The eGFR was calculated by the Chronic Kidney Dis-
ease Epidemiology Collaboration (CKD-EPI) formula.17
Acute kidney injury and acute renal failure were based
on the RIFLE (Risk, Injury, Failure, Loss, and End-
stage kidney disease) criteria.18 Early changes in renal
function were calculated by comparing the preoperative
laboratory value with that obtained on date of discharge.
Midterm renal function was determined by comparing the
discharge value and the most recent available laboratory
value.
All analysis was completed by the R statistical software
package (Vienna, Austria; V.2.15.0). Differences in renal
function were calculated by the nonparametric Kruskal-
Wallis and exact Wilcoxon scores tests. Continuous vari-
ables were analyzed by a Student t-test or Wilcoxon
Mann-Whitney test, and categorical variables were
compared with a Fisher exact test, when indicated. Long-term survival, patency, reintervention, and freedom from
MAEs were estimated by Kaplan-Meier curves and differ-
ences determined with a log-rank test. A P value < .05
was considered signiﬁcant.
RESULTS
Patient cohort. From 2008 to 2012, 1223 patients
were treated with either open (n ¼ 376) or endovascular
(n ¼ 847) surgery for abdominal and thoracoabdominal
aortic disease. Standard EVAR for infrarenal aortic aneu-
rysm was completed in 291 patients, whereas 442 patients
underwent thoracic EVAR for a variety of indications. Dur-
ing the study interval, 73 patients received fenestrated
endograft repair, which began to be offered in 2010. A to-
tal of 41 patients underwent chEVAR, which represented
5% of all endovascular repairs. These patients received 76
chimney stents (renal, n ¼ 51; superior mesenteric, n ¼
16; celiac, n ¼ 9). The demographics and comorbidities
are outlined in Table I.
Preoperative characteristics. Preoperative aneurysm
diameters, indications, and mode of presentation are high-
lighted in Table II. Fourteen patients (34%) had a history
of prior endovascular or open aortic surgery. Repair was
elective in 30 cases (73%), whereas three patients presented
with a ruptured pathologic process (juxtarenal aneurysm,
one; postsurgical pseudoaneurysm, two). Details of the
implanted chimney stents are demonstrated in Table III.
The most frequent conﬁguration consisted of either bilat-
eral renal chimneys (n ¼ 13; 32%) or a single renal along
Table III. Target vessels and chimney stent
combinations
Feature No.
Total number chimney stents implanted 76
Visceral vessels originally targeted 75
Unplanned chimney 3
Technically unable to cannulate 2
Right renal artery 26
Left renal artery 25
SMA 16
Celiac artery 9
Chimney combinations N ¼ 41, No. (%)
Bilateral renal 13 (32)
Single renal þ SMA and/or celiac 10 (24)
Single renal 7 (17)
Single celiac 5 (12)
Bilateral renal þ SMA and/or celiac 4 (10)
Single SMA 2 (5)
SMA, Superior mesenteric artery.
Table IV. Perioperative adjuncts and procedure-related
variables
Feature N ¼ 41, No. (%)
Access vessel adjuncta
Axillary conduit 9 (22)
Open iliac conduit 5 (12)
Endovascular iliac conduit 1 (2)
Iliac angioplasty/stent 3 (7)
Femoral endarterectomy 3 (7)
Iliac occlusion plug 2 (5)
Hypogastric bypass 1 (2)
Brachial-brachial bypass 1
Femorofemoral bypass 1
Common femoral interposition graft 1
Intraprocedural adjunct
Aortic cuff 9 (22)
Simultaneous TEVAR/EVAR 3 (7)
Visceral vessel fenestration 2 (5)
Graft modiﬁcation (removal stent ring) 2 (5)
Renal artery embolization 2 (5)
Hypogastric embolization 1 (2)
Subclavian artery embolization 1
Visceral stent (non-chimney) 1
Brachiocephalic chimney 1
Diameter-reducing wires 1
Atrial inﬂow balloon occlusion 1
Preoperative carotid-subclavian bypass 1
Infrainguinal vessel embolectomy 1
Procedure variable mean 6 SD or No. (%)
Cerebrospinal ﬂuid drain 7 (17)
Procedure time, minutes 269 6 123
Fluoroscopy time, minutes 88 6 56
Contrast material exposure, mL 163 6 72
Estimated blood loss, mL 456 6 376
Packed red blood cell transfusion, units 1.4 6 2.4
Primary technical success 38 (93)
Intraprocedural complication 7 (17)
Completion angiogram type Ia endoleak 1 (2)
EVAR, Endovascular abdominal aortic aneurysm repair; SD, standard
deviation; TEVAR, thoracic endovascular aortic repair.
aMultiple adjuncts were used in individual patients.
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A variety of aortic endograft and chimney stent combina-
tions were used (Supplementary Table II, online only),
with the most prevalent being a Cook Zenith bifurcated
endograft with iCAST stents (n ¼ 10; 24%).
Perioperative details. A majority of patients (n ¼ 31;
78%) had either access vessel or intraprocedural adjuncts
employed to facilitate repair. Table IV details the various
adjuncts and procedure-related variables. Two patients had
a single target vessel abandoned because of cannulation
failure, and one had type Ia endoleak at case completion
(technical success, 93%). The type Ia endoleak failed to
resolve after repeated balloon angioplasty but was not
detected on 1-month follow-up CTA. Intraoperative
complications occurred in seven cases (17%), including
graft maldeployment with unplanned mesenteric or renal
chimney (n ¼ 2) and access vessel injury requiring repair
(n ¼ 5). Two unplanned chimney stents were used in
elective cases of juxtarenal abdominal aortic aneurysm
managed initially with a Cook Zenith bifurcated endograft
and bilateral renal chimney iCAST stent graft conﬁgura-
tion. The most common access vessel injury was related to
brachial artery thrombosis (n ¼ 3) requiring thrombec-
tomy. One patient suffered axillary artery avulsion
requiring axillobrachial bypass. The remaining complica-
tion was a femoral pseudoaneurysm after percutaneous
access that underwent repair.
Postoperative outcomes. Major postoperative com-
plications developed in 20% of patients (n ¼ 8). The
30-day mortality and in-hospital mortality were 5% (n ¼ 2)
and 7% (n ¼ 3), respectively. Two patients experienced
stroke (5%), and one of these patients died in the hospital of
respiratory failure followed by a fatal malignant arrhythmia
on postoperative day 10. The second stroke patient had
signiﬁcant aphasia and a lateralizing motor deﬁcit. This
patient ultimately recovered at the time of the most recent
follow-up but had a persistent speech impediment. Themost common complication after chEVAR was secondary
to impaired renal function (exclusive of patients who un-
derwent intentional renal coverage) and was observed in
20% of cases (n ¼ 8). Two patients (5%) had a new post-
operative requirement for hemodialysis. These two patients
had thoracoabdominal aneurysms that were managed
electively with multiple telescoping chimney stents within a
sandwich aortic stent graft conﬁguration5 to the mesenteric
and renal vessels. Postoperatively, one of the subjects
developed colonic ischemia and subsequent multiorgan
failure that resulted in death on postoperative day 12. The
second patient developed pelvic and lower extremity athe-
roembolization and respiratory failure. The patient survived
hospitalization but has remained on hemodialysis. The
remaining tabulation of postoperative outcomes is outlined
in Table V.
Follow-up and midterm outcomes. At median
follow-up of 18.2 months (range, 1.4-41.5 months), 28
of 33 patients (85%) with available postoperative imaging
Table V. Perioperative outcomes of chimney
endovascular aneurysm repair (chEVAR)
Feature N ¼ 41, No. (%)
Intraoperative death 0
30-day death 2 (5)
In-hospital death 3 (7)
Unplanned reoperation 2 (5)
Any complicationa 20 (49)
Any major complication 8 (20)
Renal complication (any)b 8 (20)
eGFR decrease $25% 6 (15)
New need for hemodialysis 2 (5)
Respiratory failure/pneumonia 5 (12)
Gastrointestinal 3 (7)
Cardiac 3 (7)
Stroke/TIA 2 (5)
Spinal cord ischemia 1 (2)
Disposition
Home 26 (63)
Inpatient facility 12 (29)
eGFR, Estimated glomerular ﬁltration rate; TIA, transient ischemic attack.
aMultiple complications occurred in nine patients (21.9%).
bAcute kidney injury was deﬁned on the basis of the RIFLE (Risk, Injury,
Failure, Loss, and End-stage kidney disease) criteria.18
Fig 1. This Kaplan-Meier curve demonstrates the estimated
probability of primary stent patency up to 3 years (n ¼ 76 stents).
Overall, nine stents (one celiac, six renal, and two superior
mesenteric artery) occluded. Seven of those occlusions (9%)
occurred within 3 years. Accounting for patients with less than
3 years of follow-up, the estimated probability of primary patency
at 3 years is 85% (95% conﬁdence interval, 75%-95%). The standard
error of the mean is <10% at all displayed intervals.
Fig 2. This Kaplan-Meier curve demonstrates the estimated
probability of freedom from reintervention after chimney endo-
vascular aneurysm repair (EVAR) up to 3 years. Overall, three of
41 patients experienced the need for reintervention. Only one of
those reinterventions occurred within 3 years. Accounting for
patients with less than 3 years of follow-up, the Kaplan-Meier
estimated probability of freedom from reintervention at 3 years is
96% (95% conﬁdence interval, 88%-99%). The standard error of
the mean is <10% at all displayed intervals.
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aneurysm sac diameters. Nine patients (32%) developed
endoleak at some point during follow-up (late [>30 day]
type Ia, 7% [n ¼ 3]; type II, 10% [n ¼ 4]; indeterminate,
7% [n ¼ 3]). One patient (2%) who was initially treated for
dissection-related suprarenal aneurysm underwent open,
surgical conversion and ultimately was determined to have
Marfan syndrome. Additional postoperative anatomic
measurements of the chEVAR patients are highlighted in
Supplementary Table III (online only).Primary patency of all chimney stents was 88% 6 5%
and 85% 6 5% at 1 year and 3 years, respectively (Fig 1).
There was no signiﬁcant difference in renal or mesenteric
chimney stent patency (log-rank, P ¼ .84). The estimated
probability of freedom (6standard error mean) from rein-
tervention was 96% 6 4% at both 1 year and 3 years
(Fig 2). Corresponding freedom from MAE was 83% 6
7% and 57% 6 10% at 1 year and 3 years (Fig 3). Details
of the MAEs are cataloged in Table VI. Of note, the three
patients who experienced $25% decrease in eGFR all had
normal preoperative renal function and no intentional renal
vessel coverage. The actuarial estimated survival for all pa-
tients at 1 year and 5 years was 85% 6 6% and 65% 6 8%,
respectively (Fig 4).
DISCUSSION
The results of this analysis conﬁrm that chEVAR can be
applied to a variety of clinical situations with a high degree of
technical success. Surgical conversion is rare, and a majority
of patients experience aneurysm sac stabilization or regres-
sion. However, perioperative complications, including
access vessel injury and postoperative renal insufﬁciency,
are common. More important, with increasing follow-up
time, chimney stent thrombosis or decline in renal function
after discharge may occur at a higher rate than previously
reported.
The original description of chEVAR was reported as a
“bailout”maneuver when inadvertent renal artery coverage
occurred during EVAR.4 However, this technique has
evolved into a primary treatment strategy for a variety of in-
dications.5,8,19 Enthusiasm for chEVAR has been further
Fig 3. This Kaplan-Meier curve demonstrates the estimated prob-
ability of freedom from a major adverse event (MAE) up to 3 years
after chimney endovascular aneurysm repair (chEVAR). Overall, 13
of 41 patients suffered a MAE, which included chimney stent
thrombosis, type Ia endoleak in follow-up, reintervention, 30-day/
in-hospital death, and $25% decrease in estimated glomerular
ﬁltration rate (eGFR) after discharge. Twelve of these MAEs
occurredwithin 3 years.Accounting for patientswith less than3 years
of follow-up, the Kaplan-Meier estimated probability of freedom
fromMAEat 3 years is 57% (95% conﬁdence interval, 37%-77%). The
standard error of the mean is <10% at all displayed intervals.
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excellent short-term outcomes.6,9,14 In addition, alternative
strategies such as fenestrated/branched techniques have a
number of potential issues, including increased cost, long
wait times for customization, and a need for complex endo-
vascular skills to implant or to modify devices as well as the
requirement for industry oversight and training. In contrast,
chEVAR is a readily available technique that can be
completed with endovascular skills familiar to most prac-
ticing vascular surgeons and applied to elective and emer-
gent settings. These potential advantages of chEVAR
compared with other methods of juxtarenal or paravisceral
aortic disease management are likely primary drivers of the
rapid adoption in many centers and increasing reports in
the literature.
To date, descriptions of chEVARhave been overwhelm-
ingly optimistic, with multiple groups describing excellent
technical success ($95%) and short-term chimney patency
rates ($90%).8,19 Further, aneurysm sac stabilization or
regression is documented in more than 90% of cases.8,19
The results in the existing literature include a report from
our group, with similar ﬁndings in early follow-up.7 Despite
the generally positive tone of most publications, several se-
ries have reported postoperative complication rates ranging
from 0% to 35%.8,20-22 Eight (20%) patients in this study
experienced postoperative complications. If intraoperative
complications (n ¼ 7;17%) are tabulated with the postoper-
ative complications, the major morbidity rate was 24% (n ¼
10; some experienced intraoperative and postoperative
complications). This rate is comparable to or even exceeds
morbidity of fenestrated/branched or open repair ofjuxtarenal aneurysm disease.23-26 Katsargyris et al27 docu-
mented that postoperative renal injury occurred on average
in 18.5%, 9.8%, and 12% of juxtarenal aneurysm cases after
open surgery, fenestrated EVAR, and chEVAR, respec-
tively, which is consistent with our experience.
Notably, two patients (5%) had documented stroke in
our series, including one fatal stroke, which represents a
risk somewhat unique to chEVAR because of the required
manipulation of brachiocephalic vessels to complete the
procedure. Other investigators have also reported that
the requisite brachial access and arch manipulation during
chEVAR increases stroke risk (3.2%) compared with fenes-
trated (0.3%) or open juxtarenal aneurysm repair (0.1%)
(P ¼ .01).27
Furthermore, type Ia endoleak after chEVAR occurs at
a signiﬁcantly higher rate than after fenestrated repair (4.3%
vs 10%; P ¼ .002).27 Interestingly, this complication
occurred in only three patients (7%) in our experience.
This lower rate may in part be explained by our consistent
practice of achieving at least 20 mm of proximal seal. How-
ever, this strategy resulted in two or more chimneys being
required in 66% of cases (n ¼ 27) and may have contrib-
uted to the observed elevated rate of late chimney stent
thrombosis. Although our type Ia endoleak rate was low,
the consequences of this problem cannot be overstated.
One patient underwent conversion and the other patients
were pending reintervention at the time of manuscript prep-
aration. The cause of type Ia endoleak in chEVAR is attrib-
uted to the so-called gutters around the chimney grafts,
which reﬂect the degree of conformational change the aortic
endograft undergoes to accommodate the interposition of
the chimney stent between the aortic endograft and native
aorta. Some have reported fewer gutter issues, depending
on chimney device selection (self-expanding vs balloon-
expandable stent graft); however, greater patient numbers
are needed to determine if there are signiﬁcant differences.28
The cumulative reported chEVAR experience has
mean follow-up of only 10.7 6 1 months,7,9,14,20,29 and
a number of the MAEs in this series occurred beyond
that time. Three patients who had documented stent
thrombosis events received a Cook Zenith and Atrium
iCAST conﬁguration; however, the other three cases had
different device combinations. Notably, half of these fail-
ures occurred beyond 11.5 months and had no obvious
radiographic signs of impending failure on surveillance
CT imaging. Interestingly, more than 10 different device
combinations were used to treat nine different pathologic
processes (Supplementary Table II, online only) in our
experience. This variability could be criticized as a weakness
in our chEVAR strategy; however, a majority of these
choices have been reported, and operative planning/device
selection was predicated on device- and patient-speciﬁc
anatomic constraints.7,8,20
The chimney stent can lead to deformation and alter-
ation of branch vessel anatomy, potentially affecting
end-organ perfusion. This notion is illustrated by the three
patients in our series who experienced a $25% eGFR
decline after discharge. These patients had normal
Table VI. Description of major adverse events (MAEs) after chimney endovascular aneurysm repair (chEVAR)
Patient Original indication MAEs Time, months Outcome
1 Type Ia endoleak $25% Y eGFR 12.3 No dialysis
2 Juxtarenal AAA $25% Y eGFR 12.9 No dialysis
3 Suprarenal AAA 30-day death 0.4 Death
4 Juxtarenal AAA $25% Y eGFR 30.8 No dialysis
5 Type Ia endoleak Type Ia endoleak 34.4 Pending revision
6 Type Ia endoleak SMA chimney thrombosis 7.5 Asymptomatic
7 Juxtarenal AAA In-hospital death 1.5 Death
8 Juxtarenal AAA Bilateral renal chimney thrombosis 40.4 Dialysis, renal bypass
9 Juxtarenal AAA Bilateral renal chimney thrombosis 2.1, 10.8 Dialysis
10 Pseudoaneurysm Celiac stent thrombosis 22.2 Celiac bypass
11 Dissection with aneurysm Type Ia endoleak 14.2 Conversion
12 Pseudoaneurysm Left renal chimney thrombosis 0.5 No dialysis
13 Suprarenal AAA Left renal chimney thrombosis 11.5 No dialysis
AAA, Abdominal aortic aneurysm; eGFR, estimated glomerular ﬁltration rate (calculated by the Chronic Kidney Disease Epidemiology Collaboration
[CKD-EPI] formula17); SMA, superior mesenteric artery.
Fig 4. This Kaplan-Meier curve demonstrates the estimated
probability of survival up to 3 years after chimney endovascular
aneurysm repair (chEVAR). At 3 years, 58% (95% conﬁdence in-
terval, 39%-74%) of patients were alive after repair, which is
consistent with published reports of open aortic repair. The stan-
dard error of the mean is <10% at all displayed intervals.
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tional renal abandonment occurred during their proce-
dures. Gradual renal function decline, although a
previously reported long-term outcome in open juxtare-
nal26,30 and fenestrated endograft31 repair, occurred be-
tween 12.3 and 30.8 months postoperatively for the
chEVAR patients in this series.
The relationship of the main aortic device to the chim-
ney stent and the variability in mechanical properties that
exist between the available devices underscore the problem
with adopting these procedures without rigorous compar-
ative effectiveness data. The device-device and device-
aortic interactions are difﬁcult to predict because they
depend on numerous factors, including intrinsic device
characteristics, stent oversizing,32 and aortic wall quality
as well as the angulation, calciﬁcation, and thrombus
burden of the aorta and its branches. The outward radialforce exerted on the chimney stent by the aortic device
and the likelihood of chimney compression or target vessel
axis deviation are unpredictable, particularly given the
various device combinations and dynamic physiologic envi-
ronment of the aorta. To counteract the extrinsic compres-
sion on the chimney stent, some authors recommend
placing a second self-expanding stent within a chimney
stent graft; however, the effectiveness of this practice is
unknown.
Several additional challenges exist in trying to under-
stand optimal patient selection for chEVAR. A variety of
“high surgical risk” deﬁnitions have been reported and
most commonly are documented as a clinical impression of
the patient’s cardiologist or surgeon.6,14 This selection
bias is difﬁcult to account for because of study heterogeneity
and imprecise comorbidity severity grading. In our group’s
experience, we use a combination of the SVS comorbidity
scoring system12 and preoperative prediction of 1-year
mortality with aneurysm repair33 to facilitate decision mak-
ing about which patients to offer therapy. Indeed, this bias
is reﬂected in the fact that>90% of the patients in this series
were American Society of Anesthesiologists class 4; however,
long-term survival was consistent with published outcomes
for surgical management of abdominal aortic disease.30,34
In addition to our own chEVAR outcomes, we have
had increasing referrals for chEVAR failure leading to
open conversion,35 further tempering our enthusiasm for
these procedures. Our current practice is to avoid elective
use of chEVAR, and these techniques are generally
reserved for salvage of inadvertent renal coverage during
EVAR or for emergent procedures in prohibitively high
surgical risk patients who are too unstable to await device
modiﬁcation for surgeon-modiﬁed repair.15 When chE-
VAR is used, we adhere to the principles that the proximal
landing zone should be radiographically normal aorta, and
optimally there should be at least 20 mm of overlap be-
tween the aortic graft and chimney stent. Ideally, the target
vessel should have a downward angle to the aortic center-
line of ﬂow, and self-expanding stents are routinely used to
reinforce the chimney stent graft as well as to ease
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is encountered. In addition, we have adopted a more
aggressive imaging surveillance protocol that includes
CTA at 1 month, 3 months, and every 6 months thereafter.
This study has several important limitations. The
intrinsic limitations of a small sample size and single-
center, retrospective nature of the analysis make type II er-
ror very possible. No standardized treatment algorithm was
present during the study period, and the selection bias for
which patients receiving open or fenestrated/branched
EVAR vs chEVAR undoubtedly inﬂuenced application of
the technique. Use of a composite end point, particularly
inclusion of renal function change after discharge, could
be criticized because this is not a routinely reported
outcome in most EVAR or thoracic EVAR trials. The de-
cision to add this end point was based on the evolving liter-
ature surrounding the impact of renal function decline on
long-term mortality after endovascular or open aortic
repair.36,37 The lack of standardized use of postoperative
duplex ultrasound imaging may have led to underappreci-
ation of in-stent stenosis that may have been linked to
chimney thrombosis. However, currently there are neither
universally accepted validated duplex criteria for renal/
mesenteric stent surveillance nor a threshold that warrants
prophylactic reintervention without any pre-existing tem-
poral change in renal function. No case controls of open
or fenestrated EVAR patients were presented to provide
insight into the outcomes of these procedures in our prac-
tice. Because our selection bias evolved during the study
period, especially after 2010, when fenestrated repair
became the preferred approach, we thought that the pa-
tient populations were so different that it would be difﬁcult
to draw meaningful conclusions from this type of analysis.
Another potential limitation is that we included chim-
ney, periscope (n ¼ 2), and sandwich stent grafts (n ¼ 4)
for analysis. Two adverse events occurred in the peri-
scope/sandwich patients, and the decision to include these
patients was based on the concept that blood ﬂow is pri-
marily a pressure-driven phenomenon. The direction of
the stented visceral vessel would not be expected to differ-
entially affect the ﬂow dynamics through the stent. Instead,
the hemodynamic differences between the various chimney
techniques would be related to inertial components of the
blood, which could lead to ﬂow perturbations through the
bent portion of the chimney stent. In general, inertial com-
ponents are much less signiﬁcant than the hemodynamic el-
ements of ﬂow and therefore primarily contribute to
second-order hemodynamic effects, the impacts of which
are beyond the scope of this manuscript. However, fric-
tional forces between the chimney/periscope and sandwich
techniques may be dissimilar, potentially leading to differ-
ential risk of stent deformation.
CONCLUSIONS
This study demonstrated that chEVAR is a technique
that can be completed with a high degree of technical suc-
cess and acceptable perioperative mortality; however,
morbidity is signiﬁcant. At midterm follow-up, anincreasing rate of MAEs, including stent thrombosis and
reintervention, was observed. Because of the rate of periop-
erative complications, a lack of high-quality comparative
effectiveness studies, and the collectively short-term
follow-up available in the literature, we think that chEVAR
should not be used routinely in the elective setting but
reserved for patients who are prohibitively high risk for
an open operation or who are not candidates for other
forms of treatment, such as fenestrated/branched grafts.
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at www.jvascsurg.org.DISCUSSIONDr Timothy M. Sullivan (Minneapolis, Minn). The concept
of chimney endovascular aneurysm repair (chEVAR) is one that
made little sense to me from its inception, given the Euclidean re-
alities of placing two cylinders within another, creating “gutters”
that thrombose, creating a “pseudo-seal” at the proximal aneurysm
neck. We seem to have conveniently forgotten past lessons,
namely, that this semiliquid thrombus is able to transmit pressure
to the aneurysm sac. On the basis of careful examination of your
results, you have appropriately recommended chEVAR solely for
urgent situations; this careful analysis and introspection remains
an important hallmark of our specialty.
1. Schiro, in Annals of Vascular Surgery, reported a high inci-
dence of sac enlargement and rupture, even in patients whose
aneurysms were initially excluded. Several type I endoleaks
developed late. Given these data, should patients having chE-
VAR be observed more aggressively? When discovered, how
should gutter endoleaks be treated?
2. You report a decline in kidney function in 15% of patients, pre-
sumably in part related to partial chimney collapse. Stentplacement within the chimney may alleviate this issue, but a
perfectly cylindrical chimney theoretically creates larger gut-
ters. What are your thoughts regarding the proper balance?
3. Gutter endoleaks also occur in patients treated with snorkels
to the internal iliac arteries in patients with aortoiliac aneu-
rysms but seem to be more benign. Can you speculate on
this apparent difference?
Dr Salvatore T. Scali. Thank you, Dr Sullivan. To your ﬁrst
question regarding the surveillance protocol, I think one of the
most disconcerting things that we found in this analysis is that as
we reviewed all available postoperative imaging, even for patients
who subsequently went on to experience stent thrombosis, there
were not always clues on the postoperative computed tomography
(CT) scans that demonstrated architectural changes to the chim-
ney stent that may tip you off to the potential of impending failure.
So with respect to the question, Should these patients have more
rigorous surveillance? The short answer is that I am not certain
our data would strongly support that recommendation because
several failures occurred without clinical or radiographic signs;
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able nature of the chimney-to-aortic endograft and native aorta
interaction, we would recommend imaging at 1 month, 3 months,
and every 6 months thereafter for the ﬁrst 24 months, then prob-
ably tailor the intervals on the basis of impressions of stent architec-
ture and aneurysm sac involution.
The bigger issue, though, is the second part of your ﬁrst ques-
tion regarding how to manage a gutter leak resulting in a persistent
type Ia endoleak with sac enlargement. Some authors recommend
that you extend the repair proximally and get more overlap; how-
ever, this can be more challenging than it sounds and may require
additional chimney lengthening or visceral stenting. Notably, we
had a relatively low incidence of type Ia endoleak in our series
compared with what is reported in the literature, which is probably
related to the 25-mm average seal that was achieved with the repair
that may have consequently led to elevated rates of chimney stent
failure due to the increased overlap. With that being said, the
impact of this complication cannot be overstated as one patient un-
derwent conversion. We have a second patient who is likely to ul-
timately undergo conversion, so barring the ability to extend more
proximally, which often involves putting more chimney stents into
the renal or mesenteric vessels, I do not think that there is a
straightforward solution.
To your second question about the drop in glomerular ﬁltra-
tion rate, again, to my previous point, there were not always clues
on postoperative imaging that the patients were developing stent
deformation. However, even in vessels thought to have optimal
anatomy for chimney placement, we have seen deformation
without clinical consequences such as a change in glomerular ﬁltra-
tion rate, stent thrombosis, or abdominal pain. I would like to
bring your attention to one example. Many authors embrace the
notion that a down-going vessel is more advantageous for a chim-
ney stent procedure. The superior mesenteric artery is classically a
down-going vessel; however, these slides are an example of a su-
prarenal aortic aneurysm that was repaired with chimney EVAR
in our practice. Initial chimney placement resulted in some stent
compression without clinical symptoms or duplex velocities sug-
gestive of stenosis. However, over time, CT scans demonstrated
greater compression and eventual thrombosis, which surprisingly
and fortunately was asymptomatic for this patient. Some authors
might argue, “well, you should place additional self-expanding
stents to support the stent graft,” which highlights one of the chal-
lenges with interpreting the chimney literature. Speciﬁcally, there isno standardized technique. We used combinations of virtually all
known aortic endografts and stent/stent grafts because of the
complexity of the disease patterns we treated, and no single device
combination seemed to be more frequently associated with fail-
ures. I think it is very difﬁcult to reliably predict the biomechanical
properties of the interface between the different aortic endografts
and the various permutations of chimney stents or stent grafts
that are reported. For example, two of the patients in this series
who experienced bilateral renal chimney stent thrombosis had
stent grafts (one patient had Fluencys and a Zenith graft, one pa-
tient had Viabahns and a Gore graft) with internally supported self-
expanding Zilver stents, and they still ended up with thrombosis.
Chimney stent failure is not simply explained by architecture
and stent deformation. In an effort to try to understand the differ-
ences in hemodynamic perturbations that occur in stented visceral
vessels after chimney and fenestrated EVAR, one of my colleagues,
Scott Berceli, has some preliminary data that demonstrate that
there is tremendous variation in shear stress that occurs in the
visceral vessels after chimney stent placement. These studies may
provide mechanistic insights as to why it is that some of these
stents go on to fail even without architectural abnormalities on
CT or alterations in duplex velocities.
With respect to your third question about why it is that an in-
ternal iliac chimney with a type Ib leak may have a more benign
course compared with a type Ia leak, I am unaware of any compel-
ling clinical data that could argue for relative “safety” of one leak
compared with the other. Conceptually, from a purely ﬂow dynamic
and pressure principle argument, it should not make a difference
where the type I endoleak originates. However, I am aware that
there are some suggestions in the literature that support the notion
that type Ib internal iliac chimney leaks may be more benign. One
possible explanation is that there are different biomechanical proper-
ties of the iliac limbs compared with the hoop strength that you
encounter with an aortic endograft, leading to better conformability
between the iliac stents. Also the length of overlap is often different.
It is possible that the longer internal iliac chimney stent gutter has a
smaller cross-sectional diameter leading to relatively greater ﬂow
resistance and pressure drop compared with a shorter proximal
aortic gutter with larger diameters. Also, depending on how the in-
ternal iliac chimney is constructed, the “type Ib leak” may really be
behaving like a type II leak, depending on the conﬁguration of the
proximal aortic stent and distal external iliac seal zone, especially if
you have constructed an “internal” chimney.INVITED COMMENTARYW. Darrin Clouse, MD, Sacramento, CalifAs I read “Critical analysis of results after chimney EVAR raises
cause for concern,” by Scali and colleagues, I very much appreciated
the candor in experience and temperance in thought from the excel-
lent University of Florida group. This report describes the operative
andmonitored outcomes in 41 patients with 76 renovisceral “chim-
ney” grafts with endovascular aortic repair (chEVAR) up to a me-
dian of 18 months. Intraoperative complications occurred in 17%
and major postoperative complications in 20%, with an in-hospital
mortality of 7%; 32% of patients developed endoleak after discharge,
even with respectable “chimney neck” attained. Freedom from rein-
tervention was 96% at 3 years, with target vessel patency of 85% at 3
years. Although survival at 5 years was 65%, estimated freedom from
major adverse events (MAEs) was only 57%; 49% of this cohort
developed some type of complication! Many MAEs occurred later
than 1 year. Obvious criticisms of this small, descriptive report un-
derscore varied selection biases for differing treatments, the many
aortic disease extents included, and main body oversizing methods
as well as employment of myriad endograft/branch graft conﬁgura-
tions in the cohort. They conclude that chEVAR should be reserved
for those clearly not open candidates and those in whom fenestrated
EVAR (fEVAR) is not possible.Look, on face value, these data are really not decidedly different
from the current operative and early-term CHIMPS literature
showing surprising early success. Kastargyris1 and Donas2 have
both performed literature-pooled analysis suggesting similar aortic
and systemic outcomes for chEVAR and fEVAR, except for slightly
higher chEVAR stroke rates with transarch access from the arms.
Banno et al3 have just now communicated as much in their large
single-center report of chEVAR compared with fEVAR out to 1
year. What is different here is the suggestion of signiﬁcant later
failure.
In terms of branch and aneurysm outcomes, Scali’s somber
note is not currently corroborated in 24-month data from Europe,
where endoleak and branch occlusion rates are declared to be in
the single-digit percentage range with reasonable sac regression.4
However, issues surrounding renal function and systemic adversity
were missing. Lee and the accomplished Stanford group are also
not seeing signiﬁcant branch thrombosis, but a similar effect on
later renal function is intimated at 23 months, which they accept.5
Is the combined end point including only a $25% reduction in
estimated glomerular ﬁltration rate during the long term a fair
MAE inclusion?
Supplementary Table I (online only). Comorbidity abbreviations and deﬁnitions
Comorbidity (abbreviation) Deﬁnition
Hypertension (HTN) Chart history, any antihypertensive drug
Coronary artery disease (CAD) Chart history, angina, coronary
artery bypass, percutaneous coronary angioplasty
Chronic obstructive
pulmonary disease (COPD)
Chart history, smoking history >20 pack/years,
abnormal pulmonary function test results, medication
Smoking Current, prior if >10 pack-years
Diabetes (DM) Oral hypoglycemics, insulin
Congestive heart failure (CHF) New York Heart Association Class II or greater
Chronic renal insufﬁciency Creatinine $1.5 mg/dL, eGFR <50 mL/min/1.73 m2, or dialysis dependence13
Dyslipidemia Chart history or medication
Cerebrovascular occlusive disease(CVOD) Transient ischemic attack, stroke, carotid endarterectomy, angioplasty
Peripheral vascular occlusive disease (PVOD) Ankle-brachial index <0.9, prior peripheral arterial open or endovascular intervention
eGFR, Estimated glomerular ﬁltration rate.
Supplementary Table II (online only). Anatomic
indications and strategy for aortic endograftechimney
stent combinations
Juxtarenal aneurysm n ¼ 17
Cook Zenith þ iCast 5
Cook Zenith þ Zilver 3
Cook Zenith þ cuff þ iCast 3
Endologix þ cuff þ iCast 2
Cook Zenith þ cuff þ Viabahn/iCast 1
Gore EVAR þ Viabahn 1
Cook Zenith þ Talent cuff þ Zilver 1
Endologix þ TX2 þ iCast/Zilver 1
Suprarenal aneurysm n ¼ 7
Cook Zenith þ iCast 3
Cook Zenith þ Renu cuff þ iCast 1
Cook Zenith þ TX2 þ iCast 1
Cook Zenith þ TX2 þ iCast/Viabahn 1
Cook Zenith þ cuff þ iCast/Viabahn 1
Postsurgical pseudoaneurysm n ¼ 6
Cook Zenith þ iCast 2
Talent þ TX2 þ iCast 1
Cook Zenith þ TX2 þ iCast 1
TAG þ TX2 þ Zilver 1
Renu þ Zilver 1
Type Ia endoleak after EVAR n ¼ 3
TX2 þ iCast 2
Cook Zenith AUI þ Zilver 1
Thoracic aneurysm n ¼ 3
TX2 þ Zilver 2
Medtronic Captiva þ Viabahn 1
Type IV TAAA n ¼ 2
Zenith þ TX2 þ Viabahn
Type II TAAA n ¼ 1
Zenith þ TX2 þ iCast/Viabahn
Aortic dissection with aneurysm n ¼ 1
Zenith AUI þ TX2 þ iCast
Atheromatous disease n ¼ 1
Gore EVAR þ TAG þ Zilver
EVAR, Endovascular abdominal aortic aneurysm repair; TAAA, Crawford
extent thoracoabdominal aneurysm.
Supplementary Table III (online only). Postoperative
anatomic measurements after chimney endovascular
aortic repair (chEVAR)
Feature (N ¼ 76 chimney stents in 41 patients) No. (%)
Available postoperative CTA 33 (81)
Preoperative aortic aneurysm diameter 6 SD 65 6 12 mm
Average postoperative
change in maximal aneurysm diameter
6.0 mm
Aortic diameter at the celiac artery 26.3 mm
Aortic diameter at the SMA 26.8 mm
Aortic diameter at the lowest renal 30.8 mm
Achieved “chimney” seal zone 25.5 mm
Stent compression $50% on postoperative CTA 25 (33)
Any chimney stent thrombosis 8 (11)
Type Ia endoleak on follow-up CTA 3 (7)
CTA, Computed tomography angiography; SD, standard deviation; SMA,
superior mesenteric artery.
JOURNAL OF VASCULAR SURGERY
874.e1 Scali et al October 2014
